PLEASE JOIN US AT THE 2022 ASCO ANNUAL CONFERENCE
Are you getting the full story?
9 Posters – New Data – Take our poll and we’ll donate
PLEASE JOIN US AT THE 2022 ASCO ANNUAL CONFERENCE
Are you getting the full story?
9 Posters – New Data – Take our poll and we’ll donate
Cast your VOTE and we’ll DONATE!
We are donating $10 to the Susan G. Komen Foundation for each poll completed so visit Agendia’s 2022 ASCO booth.
AGENDIA AT THE 2022 ASCO ANNUAL CONFERENCE
Agendia will present new data from ongoing clinical research evaluating the combination of MammaPrint and BluePrint genomic tests. The Data will highlight Agendia’s clinical focus on whole transcriptome analysis as well as breast cancer care for underserved populations, in addition to several sub-studies derived from the company’s FLEX Trial, the real-world, multicenter, prospective, observational breast cancer study. Two abstracts selected by ASCO for oral discussion will feature an investigation of the ImPrint genomic test, currently for research use only, from the I-SPY trial series and an analysis from FLEX of hormone receptor-positive breast cancer in Black women classified by BluePrint.
We invite you to meet our team via live chat. We can discuss genomic testing in the pre-operative setting, or answer any questions you might have.
Poster Spotlights
Agendia will be showcasing 9 posters during this years annual oncology conference. Click here to see all posters and sessions.
Booth Information
Booth Number #19143
Please visit our booth and take our poll to help us donate to the Susan G. Komen Foundation.
Have Questions? Contact Us Today.
FOR PROVEN RESULTS
Trusted by leading physicians and institutions around the world
*Not an official event of the 2022 ASCO Annual Meeting